Daliresp
NDC 0310-0088, roflumilast, tablet, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-0088
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022522
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST250 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-0088-28 | 00310008828 | 1 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-28) / 28 TABLET in 1 BLISTER PACK |
| 0310-0088-39 | 00310008839 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-39) / 2 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c9a1d0a8-581f-4f91-a2b8-f419192d0ebfNADAC price for package 00310008828
GET /v1/drugs/nadac/00310008828NADAC price for package 00310008839
GET /v1/drugs/nadac/00310008839
Use it
Look up 0310-0088 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-0088. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.